Windlas Biotech Limited IPO

Mainboard

Pharmaceuticals & Drugs

Listed On: Aug 16, 2021 at ₹ 437 (NSE)

₹ 13800 /30 Shares

Check Allotment

Price Summary

Last Closing

876.00 (90.43%)

52 Week High

952.10

52 Week Low

311.60

Last Update

20-Sep-2024 3:30 PM

IPO Details

04 Aug, 2021

Open Date

06 Aug, 2021

Close Date

11 Aug, 2021

Allotment Date

16 Aug, 2021

Listing Date

Issue Price

₹448-460 per equity share

Face Value

₹5 Per Equity Share

Listing at Group

BSE, NSE

Registrar

Link Intime India Private Limited

List Price

437 (NSE)

Listing Date

2021-08-16

Market Lot

30 Shares (₹13,800/-)

Lead Manager

SBI Capital Markets Limited, DAM Capital Advisors Limited, IIFL Securities Limited

Issue Size

₹401.53 Crores Total : ₹ 165 Crore Fresh + 236.53 Crore OFS of 51,42,067 Shares

Retail Portion

35%

Subscription

22.47 times

IPO Docs

DRHP RHP

IPO Subscription Details

As on	QIB	NII	Retail	Total
Shares Offered / Reserved	17,45,804	13,09,354	30,55,159	61,10,317
Day 1 - 04-08-21 05:00 PM	0.00 x	0.34	6.22 x	3.18 x
Day 2 - 05-08-21 05:00 PM	0.04 x	1.11	13.40 x	7.00 x
Day 3 - 06-08-21 08:00 PM	24.10 x	15.91	24.27 x	22.47 x

Total No. of Applications: 2089000 (Approx)

Retail Subscription on the basis of Applications: 20.51 times

Valuations

Earnings Per Share (EPS)

₹7.17/-

P/E Ratio

64.17

RoNW

18.19%

Net Asset Value (NAV) - As on 31.03.201

₹109.36

Company Financials All values are in ₹ Cr.

	31-Mar-21	31-Mar-20	31-Mar-19	31-Mar-18
Assets	296.12	338.48	198.18	298.88
Revenue	430.69	331.33	311.52	356.57
Profit After Tax	15.57	16.21	63.82	11.19

About The Company

Windlas Biotech Ltd is one of the leading companies in the pharmaceutical formulations contract development and manufacturing organizations (CDMO) segment in India. The company offers a range of CDMO services from product discovery to product development, licensing, and commercial manufacturing of generic products including complex generics.

It further sells its own branded products in the trade generics and OTC markets. Currently, the focus of the company is to launch complex generic products in the chronic therapeutic category related to lifestyle-related disorders. The business operates in 3 verticals; 1. CDMO Products and services, 2. Domestic trade generics and Over-the-counter (OTC) market (nutraceutical and health supplement products), and 3. Export.

Leading pharma companies i.e. Pfizer Ltd, Sanofi India Ltd, Cadila Healthcare Ltd, Emcure Pharmaceuticals Ltd, Eris Lifesciences Ltd, Intas Pharmaceuticals Ltd, and Systopic Laboratories Private Limited are some of the marquee customers of Windlas Biotech. Its manufacturing facility is located at Dehradun with an installed operating capacity of 7,063.83 million tablets/ capsules, 54.46 million pouch/ sachet, and 61.08 million liquid bottles.

- Promoter(s)

Pre Issue Share Holding: 78%

Post Issue Share Holding: 65.16%

Company Promoter(s)

Ashok Kumar Windlass
Hitesh Windlass
Manoj Kumar Windlass
AKW WBL Family Pvt Trust

IPO - Issue Objectives

Purchase of equipment required for (i) capacity expansion of our existing facility at Dehradun Plant – IV; and (ii) addition of injectables dosage capability at our existing facility at Dehradun Plant-II;
General Corporate Purpose
To meet issue expenses
Repayment/prepayment of certain of our borrowings

IPO - Anchor Investors

Windlas Biotech mobilises Rs 120.46 crore from 22 anchor investors ahead of IPO
Marquee investors who participated in the anchor book were Macquarie, Optimix Wholesale Global Emerging Markets, Invesco Trustee, Kuber India Fund, and Elara India Opportunities Fund.
Among others, ICICI Prudential, Nippon India, UTI MF, Sundaram MF, BNP Paribas, Avendus MF, and Canara HSBC also invested in the company

IPO - FAQs

Ans. Windlas Biotech Limited IPO is a Mainboard IPO. The issue is priced at ₹448-460 per equity share. The minimum order quantity is 30 Shares. The IPO opens on Aug 4, 2021, and closes on Aug 6, 2021. Link Intime India Private Limited is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.

Ans. The Windlas Biotech Limited IPO opens on Aug 4, 2021 and closes on Aug 6, 2021.

Ans. The size of Windlas Biotech Limited IPO is ₹401.53 Crores Total : ₹ 165 Crore Fresh + 236.53 Crore OFS of 51,42,067 Shares.

Ans. The IPO price band is set between ₹448-460 per equity share.

Ans. To apply for Windlas Biotech Limited IPO IPO, follow the steps given below:

- Open the IPO Ji App or Website
- Find Windlas Biotech Limited IPO in the List of IPOs
- Press "Apply" Button
- Select Your Demat Account
- Select Your Shares Quantity and Submit
- Track Your IPO Status

Ans. The share allotment date of Windlas Biotech Limited IPO is Aug 11, 2021.

Ans. The Windlas Biotech Limited IPO will be listed on Aug 16, 2021.

Ans. Follow the steps to check the allotment status for Windlas Biotech Limited IPO here.